A monoclonal antibody-based immunoaffinity column (RAC-IAC) was developed as a cleanup method for the determination of ractopamine and ractopamine glucuronides. were fortified into 10 mL cattle urine, and loaded onto an RAC-IAC (5 mg IgG/mL) column. The column was washed and the bound analytes were eluted. In the initial loading and washing, 22% of the radioactivity was washed off and the subsequent elution step recovered 78%. A blank column prepared from nonspecific IgG retained <10% of the radioactivity. The RAC-IACs were damaged by high methanol concentrations, preventing reuse. Elution of the analytes with 50mM glycine buffer, pH 2.8, prevented damage, and the columns could be reused at least 20 times with no change in performance. They were stored >3 months in phosphate-buffered saline with 0.02% sodium azide at 4°C. The method was used with fortified cattle muscle, liver, and kidney samples with recoveries of 82.1 ± 7.6, 87.8 ± 1.9, and 92.5 ± 0.4%, respectively (n = 3). Similar studies with sheep muscle, liver, and kidney samples gave recoveries of 91.8 ± 0.2, 91.7 ± 0.3, and 92.3 ± 0.3, respectively (n = 3). Liver and kidney samples were diluted to prevent column plugging, but all of the eluants were suitable for liquid chromatography analysis. This IAC is a selective, efficient, and economical cleanup method in a variety of matrixes for ractopamine determination.
R
actopamine is a phenethanolamine leanness-enhancing agent that has been approved by the U.S. Food and Drug Administration (FDA; 1, 2) and regulatory agencies in Brazil, Venezuela, Colombia, Guatemala, Dominican Republic, and the Philippines as a feed additive for swine (3) . In addition, ractopamine in combination with tylosin has been approved to improve feed efficiency, increase carcass leanness, and prevent and control proliferative enteropathies (ileitis) in swine (4) . Phenethanolamine β-agonists have a history of being used for unauthorized purposes by livestock producers (5, 6) . The presence of drug residues in animal tissues is a potential food safety concern, especially when the compound has been used illegally or in a manner not prescribed by regulatory officials.
For residue analysis, the analyte is separated from the matrix by liquid-liquid or solid-phase extraction (SPE), followed by liquid or gas chromatography (LC or GC) or immunological analysis. Sample preparation steps are often time consuming and tedious, making an efficient cleanup method very desirable when high throughput is required.
Immunoaffinity chromatography provides a selective method to isolate and concentrate analytes from matrixes. This technique has a wide range of applications for a variety of chemical classes in a number of diverse matrixes, including sulfonamides in swine meat (7) , clenbuterol in plasma (8) , dioxins in serum (9) , and polycyclic aromatic hydrocarbons in corals (10) . Several papers reviewing this technique have been published recently (11) (12) (13) (14) . The objective of the present report is to describe the development and application of a monoclonal antibody-based immunoaffinity column (IAC) for determination of the β-adrenergic agonist ractopamine in urine, liver, muscle, and kidney of food animals. -Specific activity 712 dpm/µg, were synthesized and isolated as described by Smith et al. (15) , and contained 19.5% of peak A (ractopamine glucuronide A), 11.4% of peak B (ractopamine glucuronide B), and 68.2% peak C (ractopamine glucuronide C). Unless otherwise indicated, the mixture was used. Ractopamine glucuronide A, conjugated at the butylamine phenol of ractopamine, was composed of 66 and 33% of the (1S, 3R) and (1R, 3S) stereoisomers, respectively. Ractopamine glucuronide B, also conjugated at the butylamine phenol of ractopamine, had equal quantities of the (1R, 3R) and (1S, 3S) stereoisomers. Ractopamine glucuronide C was conjugated at the ethanolamine phenol of ractopamine and was composed of 27, 19, 28, and 26% (1R, 3R), (1S, 3R), (1S, 3S), and (1R, 3S) ractopamine stereoisomers, respectively. Ractopamine stereoisomers were synthesized as described previously (16) .
Experimental

Reagents and Supplies
(e) Liquid scintillation cocktail (Ecoliteä).-ICN Biomedical, Inc. (Costa Mesa, CA).
(f) Animal specimens.-Urine samples were obtained from cattle known to be free of ractopamine and were pooled. Cattle liver and muscle samples were purchased from a local supermarket. Cattle kidneys were obtained from North Dakota State University (Fargo, ND). Sheep liver, muscle, and kidney were obtained from a local abattoir. All other chemicals or solvents were obtained from Aldrich (Milwaukee, WI) or Sigma (St. Louis, MO) and were analytical grade or better.
Immunoaffinity Column Generation
Monoclonal antibody 5G10, raised against ractopamine (17) , was used to generate the IAC. Harlan Bioproducts for Science, Inc. (Indianapolis, IN) generated ascites fluid. In pilot studies, 1 × 10 6 , 3 × 10 6 , or 5 × 10 6 cells were injected into peritoneal cavities of primed mice. The pilot studies revealed that 3 × 10 6 cells was the optimal cell density to produce the highest concentration of IgG in the ascites; therefore, this amount was used to generate ascites. IgG was isolated from mouse ascites in a 10 mL protein-G column. In initial small-scale studies, ascites were directly diluted (1:3) with phosphate-buffered saline (PBS) prior to loading the column. For the isolation of large quantities of IgG, 50 mL ascites fluid was treated with 30% ammonium sulfate, and the precipitated protein was dissolved in 17 mL PBS. Reconstituted protein was loaded onto the protein-G column, and the nonbound material was removed with PBS. Immunoglobulin G was eluted with 50mM glycine, pH 2.8. The protein was quantified by the Bradford method (18) , and the purity was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
A 5 mg amount of IgG was conjugated to 1 mL CNBr-Sepharose 4B according to manufacturer's direction. Conjugated gel beads were stored in PBS-0.02% sodium azide at 4°C until used. IACs were prepared by packing IgG-conjugated gel beads (1 mL gel beads containing 5 mg IgG) into 5 mL plastic screening columns (Fisher Scientific, Pittsburgh, PA, Cat. No. 11-387-50). The same procedure was followed with a nonspecific IgG to prepare a control column. The nonspecific IgG was a monoclonal antibody (DD3) structurally not related to ractopamine and directed toward dioxins. Consequently, the control column should show no specific binding toward ractopamine or any of its metabolites. ]ractopamine glucuronides were loaded onto a 1 mL column (control-or RAC-IAC) and washed sequentially with 10 mL each of 10% aqueous MeOH (v/v), 50% aqueous MeOH (v/v), and 100% MeOH. Eluants (10 mL for each fraction) were collected, and radioactivity was counted with a liquid scintillation counter (TRI-CARB 1900TR, Packard Instrument Co., Downers Grove, IL). Alternatively, analytes were eluted from the column with 10 mL 50mM glycine (pH 2.8) after the column was washed with 10 mL 10% aqueous MeOH. Eluents were allowed to flow through all columns by gravity flow.
IAC Application
(b) Ractopamine metabolites.-Ten micrograms each of [ 14 C]-ractopamine glucuronide A, B, or C was fortified in 10 mL water and loaded onto a 1 mL RAC-IAC. Columns were then washed sequentially with 10 mL each of 10% aqueous MeOH (v/v), 50% aqueous MeOH (v/v), and 100% MeOH. Eluants (10 mL for each fraction) were collected, and radioactivity was counted with a liquid scintillation counter.
(c) Ractopamine stereoisomers.-Ten micrograms each of the pure RR, RS, SR, and SS stereoisomers of ractopamine were fortified in 10 mL water and loaded onto a 1 mL IAC. Columns were then washed sequentially with 10 mL each of 10% aqueous MeOH (v/v), 50% aqueous MeOH (v/v), and 100% MeOH. Each fraction was dried by centrifugal evaporation (Savant, Holbrook, NY); redissolved in 10 mL 50mM ammonium acetate, pH 4.5, 2% CH 3 CN, and mixed with a Vortex mixer; and quantified by LC with racemic ractopamine as the calibration standard (concentrations 50, 100, 200, 400, 800, 1600, and 3200 ng/mL) with 50 µL injection volume for both analytes and standards.
Solid-Phase Extraction of Ractopamine in Urine
The procedure for SPE of ractopamine in urine has been described previously (19) . Briefly, 250 ng racemic ractopamine was fortified into 1 mL urine and passed through a preconditioned C 18 SPE cartridge (500 mg; Bakerbond ® , J.T. Baker, Phillipsburg, NJ) and washed with 5 mL each of water and 50% MeOH-H 2 O; the ractopamine was eluted with 5 mL 50% MeOH-ammonium acetate buffer (0.05M, pH 4.5). The eluants were evaporated with centrifugal evaporation and reconstituted with 250 µL 50mM ammonium acetate, pH 4.5, 2% CH 3 CN. A 50 µL volume of the reconstituted eluants was analyzed by LC and compared with similar eluants obtained from IAC isolation of ractopamine. This allowed direct comparison of the sample preparation methods.
Liquid Chromatography
Eluants collected from the IACs of fortified tissue and urine samples were chromatographed to determine whether interfering substances were present in fractions containing ractopamine. The LC system consisted of a Waters (Milford, MA) 600 E pump, Model 717 autosampler, Model 746 data module, and a Jasco (Tokyo, Japan) FP920 fluorescence detector. Samples were chromatographed on a Waters Resolve ® C 18 column (3.9 × 150 mm, 5 µm) or Phenomenex (Torrance, CA) Prodigy ODS-3 column (4.6 × 250 mm, 5 µm) with an aqueous mobile phase containing 280 mL acetonitrile, 720 mL water, 20 mL acetic acid, and 1.08 g 1-octanesulfonic acid/L with a flow rate of 1 mL/min. The analytes were measured by fluorescence detection with excitation at 226 nm and emission at 305 nm. A ractopamine standard was used in each run to ensure column performance.
IAC Stability
IACs were subjected to multiple loadings and elutions to determine column stability. Columns were loaded with 5 µg ]ractopamine glucuronide, washed with 10 mL 10% MeOH, and eluted with either 10 mL 100% MeOH or 10 mL 50mM glycine (pH 2.8). All eluants were counted in a liquid scintillation counter to determine recovery. Between uses, columns were stored at 4°C in PBS-0.02% NaN 3 (pH 7.2). Columns eluted with 100% methanol were used for only 3 elutions because of obvious stability problems.
Preparation of Muscle, Kidney, and Liver Samples
A 10 g test portion of tissue was added to 10 mL PBS (pH 7.2), and the mixture was homogenized for 1 min with a Tissumizer ® (Tekmar Co., Cincinnati, OH) set at high torque. Samples were then cooled in an ice bath. This was repeated until no large particles were visually observed (usually 2-4 homogenization cycles). Supernatants were separated from tissue debris by centrifugation at 12 000 × g and stored at -20°C until used.
IAC of Muscle Samples
Extracts (ca 8 mL) from 10 g muscle samples were each fortified with 5 µg [ Columns were washed with 10 column volumes of 10% aqueous MeOH, and the bound material was eluted with 10 mL 50mM glycine, pH 2.8. Eluants were evaluated for column recoveries of radioactivity by liquid scintillation counting. Fractions were also analyzed by LC to determine the suitability of IAC as a preparation method for the LC determination of ractopamine.
IAC of Liver and Kidney Samples
Liver or kidney extracts were diluted 1:5 with PBS, pH 7.2, to a final volume of 10 mL and fortified with 5 µg each of [ 14 C]ractopamine and [ 14 C]ractopamine glucuronide. Dilution was required to avoid plugging the column. Samples were applied to 1 mL RAC-IAC, and columns were washed and eluted. Glycine eluants were analyzed by liquid scintillation counting or LC as described above.
Precision and Accuracy of IAC
Samples of 100, 1000, 2500, and 5000 ng ractopamine racemic mixture were fortified in 10 mL urine and loaded onto a 1 mL IAC. These represent 10, 100, 250, and 500 ppb fortified ractopamine samples. Columns were than washed with 10 mL 10% MeOH (v/v) and eluted with 10 mL 10mM glycine (pH 2.8). Ractopamine in the glycine eluant was quantified by LC with racemic ractopamine as the calibration standard, as described in the previous section. The procedure was repeated 3 times for each fortification level. For the lowest concentration (10 ng/mL) the eluant was evaporated, the residue was reconstituted in 250 µg LC solvent, and 50 µL was injected. For the other samples, the eluant (10 mL) was directly injected into the LC system (100 µL for the 100 ng/mL samples and 50 µL for the 250 and 500 ng/mL samples).
IAC of Incurred Urine Samples
A 1 mL aliquot of incurred urine from a ractopamine feeding study (19; Cow 157 withdrawal day 0) was loaded onto either IAC or SPE columns (n = 3). The SPE column procedure was the same as described above. The IAC procedure used the glycine eluant. The eluants were evaporated by centrifugation and reconstituted in 250 µL 50mM ammonium acetate, pH 4.5, in 2% CH 3 incurred urine samples was quantified by LC with racemic ractopamine used as the calibration standard, as described earlier.
Results and Discussion
A pilot study was performed to determine the optimum number of cells needed to produce maximum IgG concentration. This study showed that for the ractopamine monoclonal antibody cell line 5G10, 1 × 10 6 cells produced 2.6 mg IgG/mL ascites, 3 × 10 6 cells produced 4.3 mg IgG/mL ascites, and 5 × 10 6 cells produced 3.0 mg IgG/mL ascites. Clearly, the number of cells was critical for optimum antibody production, although all levels produced substantial quantities of antibody. Subsequent efforts to generate large-scale amounts of ascites used preparations of 3 ×10
6 cells.
To demonstrate the IAC specificity towards ractopamine, selectivity of the ractopamine IAC was compared with an identical column prepared with control IgG that was not generated toward ractopamine. The control IAC retained <6% of the applied radioactivity (Table 1) with >90% of the applied radioactivity eluted during sample loading and with the 10% aqueous methanol column wash. In contrast, approximately 80% of the applied radioactivity was retained on the ractopamine-specific IAC and was eluted only by aqueous methanol at concentrations of ≥50% or with glycine buffer. These results show that ractopamine was specifically retained by the ractopamine IAC, but not by the control column.
Elution of ractopamine from the IAC with glycine resulted in excellent recovery of the radiolabel (89%) and offered 2 main advantages over elution with methanol. First, elution with glycine buffer resulted in cleaner chromatograms of parent ractopamine after fortification in urine samples (Figure 1) . Elution with methanol resulted in the coelution of fluorescent compounds that interfered with chromatographic analysis of ractopamine (Figure 1) . Second, IACs were stable after glycine buffer was used, whereas columns eluted sequentially with solvents containing a high percentage of methanol rapidly degraded (discussed below). The major disadvantage of using glycine as the eluting buffer is the increased amount of time required to concentrate it (i.e., by evaporation) relative to methanol.
IAC with glycine elution appeared to be a superior cleanup method to the C 18 SPE for isolation of ractopamine from urine ( Figure 1) . SPE of urine samples resulted in a "shoulder" peak of ractopamine, which was not completely resolved, whereas this interference was not present in chromatograms of glycine fractions from the IACs. Although the shoulder peak from urine samples can be eliminated (19) , an extra liquid-liquid extraction step is necessary. For rapid analysis of multiple samples, IAC is potentially more useful than SPE.
The stereochemistry of ractopamine markedly affected its column retention (Figure 2) , as might be expected for an IAC constructed from a stereoselective antibody (17) . The RS isomer was not retained by the IAC, whereas the RR, SR, and SS isomers were retained and eluted by 50 and 100% methanol. The affinity of a compound for the antibody can be measured by its IC 50 , the concentration of competitor that produces 50% of the absorbance compared with no competitor. Previously we found that the IC 50 for the RS isomer of ractopamine was 291 ng/mL compared with IC 50 values of 140, 2, and 0.5 ng/mL for the SS, SR, and RR ractopamine stereoisomers, respectively (17) . Antibody binding to ractopamine glucuronides was also regiospecific; glucuronides conjugated to the ethanolamine phenol (ractopamine glucuronide C) had a much greater affinity (IC 50 of 0.7 ng/mL) for the antibody than did ractopamine glucuronides A and B (conjugated to the butylamine phenol and having IC 50 values of 263 and 88 ng/mL, respectively; 17). Consistent with these results, ractopamine glucuronide C was the primary glucuronide present in the 50 and 100% MeOH washes of the IAC. Ractopamine glucuronide A eluted primarily during sample loading and column rinsing with 10% MeOH, although some was recovered in the bound fraction. Ractopamine glucuronide B eluted primarily in the bound fraction, with some eluted during the loading and 10% MeOH washing steps. The retention of both ractopamine and ractopamine glucuronides is consistent with the IC 50 measurement reported earlier (17) .
In stability tests, ractopamine IACs quickly degraded when eluted with >50% methanol and showed marked performance problems in the second use (Figure 3) . However, when 50mM glycine, pH 2.8, was used to elute the analytes, only minimal decreases in column capacity occurred after 20 uses. Furthermore, ractopamine IACs stored at 4°C in PBS-0.02% sodium azide were stable over 3 months (Figure 3) . Because of the apparent advantages of glycine elution, subsequent studies on the effects of matrix (urine, muscle, kidney, and liver) were performed with glycine as the elution solvent. Fortified cattle muscle extracts were directly loaded onto IACs and washed with 10% methanol; 82.1 ± 7.6% of the ractopamine glucuronide standard was recovered in glycine buffer. Analysis of the liver sample extracts required a 1:5-fold dilution with PBS to avoid plugging the IACs. The recovery from the IAC was 87.8 ± 1.9% (n = 3) for liver samples and 92.5 ± 0.4% (n = 3) for kidney extracts. Examination of IAC eluates by LC demonstrated baseline resolution of ractopamine and interfering substances in all of the matrixes tested (Figure 4 ). Sheep muscle, kidney, and liver extracts had 91.8 ± 0.2, 92.7 ± 0.6, and 91.7 ± 0.3% recovery of spiked [ 14 C] ractopamine/ractopamine glucuronides, respectively (n = 3). Again, liver and kidney extracts had to be diluted 1:5 with PBS before application to the IAC.
The validated regulatory method for the detection of parent ractopamine in swine muscle and liver samples (B03766, Center for Veterinary Medicine's Document Control Unit, FDA, Rockville, MD) requires the tissue be ground, ractopamine extracted with methanol, an aliquot of the extract evaporated, borate buffer added, and the ractopamine extracted into ethyl acetate by liquid-liquid partition. The sample is further purified by using acidic alumina SPE before LC analysis. Our IAC method is simpler and does not require liquid-liquid partition. Our method results in a clean sample and has the potential advantage of isolating both parent ractopamine and ractopamine metabolites. Because the assay could also be used to screen for illicit use, isolation by IAC of the major ractopamine metabolites will enable the method to more accurately detect illicit use even after a withdrawal period. The IAC eluant is quite clean, and therefore various methods could be used to quantify the metabolites.
Spiked ractopamine urine samples were used to determine the precision and recovery at various ractopamine levels. The recoveries of ractopamine from the urine samples for 10, 100, 250, and 500 ng/mL were 80.7, 92.6, 86.3, and 90.0%, respectively. The standard errors of the measurements were 3.5, 13.1, 6.7, and 3.5%, respectively. The IAC gives excellent recovery and reproducibility. The clean sample from the IAC allows the sensitivity to be easily controlled by concentrating the eluant to obtain greater sensitivity. The method is useful over a very wide range of concentrations with only minor alterations in the LC procedure.
To further validate the method, a direct comparison was made of incurred urine samples by using a validated SPE method versus our current IAC method. The 2 methods gave nearly identical results: 134.4 ± 3.7 ng/mL for SPE versus 142 ± 4.7 ng/mL for IAC. The 2 means differed by <6% and had comparative reproducibility. Thus, we have demonstrated the method is applicable to incurred samples of the type that might be encountered in the field.
Conclusions
Ractopamine IACs provided a simple, efficient sample cleanup process. The procedure produced columns of consistent quality with good retention of ractopamine and clean elution of ractopamine with a simple glycine buffer. The columns were stable when stored, and could be reused multiple times.
